Tuning protein folding in lysosomal storage diseases: the chemistry behind pharmacological chaperones
出版年份 2018 全文链接
标题
Tuning protein folding in lysosomal storage diseases: the chemistry behind pharmacological chaperones
作者
关键词
-
出版物
Chemical Science
Volume 9, Issue 7, Pages 1740-1752
出版商
Royal Society of Chemistry (RSC)
发表日期
2018-01-10
DOI
10.1039/c7sc04712f
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- A pooled analysis of adverse events in 393 adults with Gaucher disease type 1 from four clinical trials of oral eliglustat: Evaluation of frequency, timing, and duration
- (2018) M. Judith Peterschmitt et al. BLOOD CELLS MOLECULES AND DISEASES
- Twelve years of experience with miglustat in the treatment of type 1 Gaucher disease: The Spanish ZAGAL project
- (2018) Pilar Giraldo et al. BLOOD CELLS MOLECULES AND DISEASES
- Patients with Gaucher type 1: Switching from imiglucerase to miglustat therapy
- (2018) Ebru Canda et al. BLOOD CELLS MOLECULES AND DISEASES
- Efficacy and safety of migalastat, an oral pharmacologic chaperone for Fabry disease: results from two randomized phase 3 studies, FACETS and ATTRACT
- (2017) Ulla Feldt-Rasmussen et al. MOLECULAR GENETICS AND METABOLISM
- Oral ambroxol increases brain glucocerebrosidase activity in a nonhuman primate
- (2017) Anna Migdalska-Richards et al. SYNAPSE
- Investigation of original multivalent iminosugars as pharmacological chaperones for the treatment of Gaucher disease
- (2016) Eugénie Laigre et al. CARBOHYDRATE RESEARCH
- Glycomimetic-based pharmacological chaperones for lysosomal storage disorders: lessons from Gaucher, GM1-gangliosidosis and Fabry diseases
- (2016) Elena M. Sánchez-Fernández et al. CHEMICAL COMMUNICATIONS
- Oral pharmacological chaperone migalastat compared with enzyme replacement therapy in Fabry disease: 18-month results from the randomised phase III ATTRACT study
- (2016) Derralynn A Hughes et al. JOURNAL OF MEDICAL GENETICS
- Bone mineral density in Morquio syndrome type B
- (2016) Francyne Kubaski et al. MOLECULAR GENETICS AND METABOLISM
- Recommendations for the use of eliglustat in the treatment of adults with Gaucher disease type 1 in the United States
- (2016) Manisha Balwani et al. MOLECULAR GENETICS AND METABOLISM
- Docking study and biological evaluation of pyrrolidine-based iminosugars as pharmacological chaperones for Gaucher disease
- (2016) Atsushi Kato et al. ORGANIC & BIOMOLECULAR CHEMISTRY
- Ambroxol chaperone therapy for neuronopathic Gaucher disease: A pilot study
- (2016) Aya Narita et al. Annals of Clinical and Translational Neurology
- pH-Responsive Pharmacological Chaperones for Rescuing Mutant Glycosidases
- (2015) Teresa Mena-Barragán et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Lysosomal Storage Diseases: From Pathophysiology to Therapy
- (2015) Giancarlo Parenti et al. Annual Review of Medicine
- N-Alkyl-, 1-C-Alkyl-, and 5-C-Alkyl-1,5-dideoxy-1,5-imino-(l)-ribitols as Galactosidase Inhibitors
- (2015) Sophie Front et al. ChemMedChem
- Azasugar inhibitors as pharmacological chaperones for Krabbe disease
- (2015) Chris H. Hill et al. Chemical Science
- Pharmacological Chaperones and Coenzyme Q10 Treatment Improves Mutant β-Glucocerebrosidase Activity and Mitochondrial Function in Neuronopathic Forms of Gaucher Disease
- (2015) Mario de la Mata et al. Scientific Reports
- Gaucher disease: haematological presentations and complications
- (2014) Alison S. Thomas et al. BRITISH JOURNAL OF HAEMATOLOGY
- Chaperone therapy for homocystinuria: the rescue of CBS mutations by heme arginate
- (2014) Petra Melenovská et al. JOURNAL OF INHERITED METABOLIC DISEASE
- Natural course of Fabry disease and the effectiveness of enzyme replacement therapy: a systematic review and meta-analysis
- (2014) Saskia M. Rombach et al. JOURNAL OF INHERITED METABOLIC DISEASE
- Pharmacological chaperones increase residual β-galactocerebrosidase activity in fibroblasts from Krabbe patients
- (2014) Anna Sara Berardi et al. MOLECULAR GENETICS AND METABOLISM
- Pharmacological chaperoning: A primer on mechanism and pharmacology
- (2014) Nancy J. Leidenheimer et al. PHARMACOLOGICAL RESEARCH
- Anti-Prion Activity of a Panel of Aromatic Chemical Compounds: In Vitro and In Silico Approaches
- (2014) Natalia C. Ferreira et al. PLoS One
- Chaperones Ameliorate Beta Cell Dysfunction Associated with Human Islet Amyloid Polypeptide Overexpression
- (2014) Lisa Cadavez et al. PLoS One
- The therapeutic potential of chemical chaperones in protein folding diseases
- (2014) Leonardo Cortez et al. Prion
- Skeletal improvement in patients with Gaucher disease type 1: a phase 2 trial of oral eliglustat
- (2014) Ravi S. Kamath et al. SKELETAL RADIOLOGY
- The Biogenesis of Lysosomes and Lysosome-Related Organelles
- (2014) J. P. Luzio et al. Cold Spring Harbor Perspectives in Biology
- Chemical Chaperones Mitigate Experimental Asthma by Attenuating Endoplasmic Reticulum Stress
- (2013) Lokesh Makhija et al. AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY
- 4-Phenylbutyric acid protects against neuronal cell death by primarily acting as a chemical chaperone rather than histone deacetylase inhibitor
- (2013) Seisuke Mimori et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- A Systematic Investigation of Iminosugar Click Clusters as Pharmacological Chaperones for the Treatment of Gaucher Disease
- (2013) Antoine Joosten et al. CHEMBIOCHEM
- The Unfolded Protein Response and Chemical Chaperones Reduce Protein Misfolding and Colitis in Mice
- (2013) Stewart Siyan Cao et al. GASTROENTEROLOGY
- Pharmacological Chaperones as Therapeutics for Lysosomal Storage Diseases
- (2013) Robert E. Boyd et al. JOURNAL OF MEDICINAL CHEMISTRY
- Gangliosides and Gangliosidoses: Principles of Molecular and Metabolic Pathogenesis
- (2013) K. Sandhoff et al. JOURNAL OF NEUROSCIENCE
- Pilot study using ambroxol as a pharmacological chaperone in type 1 Gaucher disease
- (2012) Ari Zimran et al. BLOOD CELLS MOLECULES AND DISEASES
- Potent Aminocyclitol Glucocerebrosidase Inhibitors are Subnanomolar Pharmacological Chaperones for Treating Gaucher Disease
- (2012) Ana Trapero et al. JOURNAL OF MEDICINAL CHEMISTRY
- Rapid Assembly of a Library of Lipophilic Iminosugars via the Thiol–Ene Reaction Yields Promising Pharmacological Chaperones for the Treatment of Gaucher Disease
- (2012) Ethan D. Goddard-Borger et al. JOURNAL OF MEDICINAL CHEMISTRY
- Identification and Characterization of Pharmacological Chaperones to Correct Enzyme Deficiencies in Lysosomal Storage Disorders
- (2011) Kenneth J. Valenzano et al. ASSAY AND DRUG DEVELOPMENT TECHNOLOGIES
- Crystal Structure of Human β-Galactosidase
- (2011) Umeharu Ohto et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Amphiphilic 1-Deoxynojirimycin Derivatives through Click Strategies for Chemical Chaperoning in N370S Gaucher Cells
- (2011) Jennifer D. Diot et al. JOURNAL OF ORGANIC CHEMISTRY
- Insights into Krabbe disease from structures of galactocerebrosidase
- (2011) J. E. Deane et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Non-iminosugar glucocerebrosidase small molecule chaperones
- (2011) Juan Jose Marugan et al. MedChemComm
- 2,5-Dideoxy-2,5-imino-d-altritol as a new class of pharmacological chaperone for Fabry disease
- (2010) Atsushi Kato et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Fluorous Iminoalditols: A New Family of Glycosidase Inhibitors and Pharmacological Chaperones
- (2010) Georg Schitter et al. CHEMBIOCHEM
- Identification and characterization of 15 novel GALC gene mutations causing Krabbe disease
- (2010) Barbara Tappino et al. HUMAN MUTATION
- Molecular Characterization of Mutations That Cause Globoid Cell Leukodystrophy and Pharmacological Rescue Using Small Molecule Chemical Chaperones
- (2010) W. C. Lee et al. JOURNAL OF NEUROSCIENCE
- DLHex-DGJ, a novel derivative of 1-deoxygalactonojirimycin with pharmacological chaperone activity in human GM1-gangliosidosis fibroblasts
- (2010) Katrin Fantur et al. MOLECULAR GENETICS AND METABOLISM
- Chaperone Activity of Bicyclic Nojirimycin Analogues for Gaucher Mutations in Comparison withN-(n-nonyl)Deoxynojirimycin
- (2009) Zhuo Luan et al. CHEMBIOCHEM
- Identification and Characterization of Ambroxol as an Enzyme Enhancement Agent for Gaucher Disease
- (2009) Gustavo H. B. Maegawa et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- The pharmacological chaperone 1-deoxygalactonojirimycin increases α-galactosidase A levels in Fabry patient cell lines
- (2009) E. R. Benjamin et al. JOURNAL OF INHERITED METABOLIC DISEASE
- Rational Design and Synthesis of Highly Potent Pharmacological Chaperones for Treatment of N370S Mutant Gaucher Disease
- (2009) Guan-Nan Wang et al. JOURNAL OF MEDICINAL CHEMISTRY
- Miglustat (Zavesca®) in type 1 Gaucher disease: 5-year results of a post-authorisation safety surveillance programme
- (2009) Carla E. M. Hollak et al. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY
- Molecular Basis for β-Glucosidase Inhibition by Ring-Modified Calystegine Analogues
- (2008) Matilde Aguilar et al. CHEMBIOCHEM
- Ambroxol in the 21st century: pharmacological and clinical update
- (2008) Mario Malerba et al. Expert Opinion on Drug Metabolism & Toxicology
- Preclinical Efficacy and Safety of 1-Deoxygalactonojirimycin in Mice for Fabry Disease
- (2008) S. Ishii et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now